LaGanke, Christopher et al "Safety/tolerability of the anti-semaphorin 4D antibody VX15/2503 in a randomized phase 1 trial." Neurology - Neuroimmunology Neuroinflammation 4.4 (2017): e367. Web. 03 Dec. 2021.